NO995480D0 - Eksitatoriske aminosyrereseptormodulatorer - Google Patents
Eksitatoriske aminosyrereseptormodulatorerInfo
- Publication number
- NO995480D0 NO995480D0 NO995480A NO995480A NO995480D0 NO 995480 D0 NO995480 D0 NO 995480D0 NO 995480 A NO995480 A NO 995480A NO 995480 A NO995480 A NO 995480A NO 995480 D0 NO995480 D0 NO 995480D0
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- receptor modulators
- acid receptor
- excitatory amino
- excitatory
- Prior art date
Links
- 102000018899 Glutamate Receptors Human genes 0.000 title 1
- 108010027915 Glutamate Receptors Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/52—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/14—Compounds containing azido groups with azido groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/383—Cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4701197P | 1997-05-14 | 1997-05-14 | |
| PCT/US1998/009862 WO1998051655A1 (fr) | 1997-05-14 | 1998-05-14 | Modulateurs de recepteur d'acides amines excitateurs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO995480L NO995480L (no) | 1999-11-09 |
| NO995480D0 true NO995480D0 (no) | 1999-11-09 |
Family
ID=21946570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO995480A NO995480D0 (no) | 1997-05-14 | 1999-11-09 | Eksitatoriske aminosyrereseptormodulatorer |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US5958960A (fr) |
| EP (1) | EP0878463B1 (fr) |
| JP (1) | JP4191263B2 (fr) |
| KR (1) | KR20010012489A (fr) |
| CN (1) | CN1125807C (fr) |
| AR (1) | AR015664A1 (fr) |
| AT (1) | ATE198190T1 (fr) |
| AU (1) | AU729632B2 (fr) |
| BR (1) | BR9808787A (fr) |
| CA (1) | CA2289472C (fr) |
| CO (1) | CO4950558A1 (fr) |
| DE (1) | DE69800430T2 (fr) |
| DK (1) | DK0878463T3 (fr) |
| EA (1) | EA199901029A1 (fr) |
| ES (1) | ES2152738T3 (fr) |
| GR (1) | GR3035156T3 (fr) |
| HU (1) | HUP0001404A3 (fr) |
| ID (1) | ID23183A (fr) |
| IL (1) | IL132894A0 (fr) |
| NO (1) | NO995480D0 (fr) |
| NZ (1) | NZ500954A (fr) |
| PE (1) | PE73599A1 (fr) |
| PL (1) | PL336793A1 (fr) |
| PT (1) | PT878463E (fr) |
| SI (1) | SI0878463T1 (fr) |
| SV (1) | SV1998000056A (fr) |
| TR (1) | TR199902777T2 (fr) |
| TW (1) | TW505623B (fr) |
| WO (1) | WO1998051655A1 (fr) |
| ZA (1) | ZA983930B (fr) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| DK1052246T3 (da) * | 1998-01-28 | 2003-06-16 | Taisho Pharmaceutical Co Ltd | Fluorholdige aminosyrederivater |
| CN1247527C (zh) * | 1998-08-31 | 2006-03-29 | 大正制药株式会社 | 6-氟双环[3.1.0]己烷衍生物 |
| PE20001236A1 (es) * | 1998-11-13 | 2000-11-10 | Lilly Co Eli | Moduladores del receptor de aminoacidos excitadores |
| DK1142860T3 (da) * | 1998-12-18 | 2004-11-22 | Taisho Pharmaceutical Co Ltd | Mellemprodukter og fremgangsmåde til fremstilling af en fluorholdig aminosyreforbindelse ved anvendelse deraf |
| JP4505926B2 (ja) * | 1999-03-25 | 2010-07-21 | 大正製薬株式会社 | 新規カルボン酸誘導体及びその製造方法 |
| US6479674B1 (en) | 1999-03-25 | 2002-11-12 | Taisho Pharmaceutical Co., Ltd. | Carboxylic acid derivatives and process for producing same |
| US6528499B1 (en) * | 2000-04-27 | 2003-03-04 | Georgetown University | Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| AU773915B2 (en) | 1999-04-28 | 2004-06-10 | Georgetown University | Ligands for metabotropic glutamate receptors |
| US6417366B2 (en) * | 1999-06-24 | 2002-07-09 | Abbott Laboratories | Preparation of quinoline-substituted carbonate and carbamate derivatives |
| JP4783967B2 (ja) * | 1999-07-21 | 2011-09-28 | 大正製薬株式会社 | 含フッ素アミノ酸誘導体を有効成分とする医薬 |
| WO2001042203A1 (fr) * | 1999-12-08 | 2001-06-14 | Eli Lilly And Company | Derives de sulfonamide de cyclopentyle |
| US6639107B1 (en) | 1999-12-08 | 2003-10-28 | Eli Lilly And Company | Cyclopentyl sulfonamide derivatives |
| IL156364A0 (en) * | 2001-01-11 | 2004-01-04 | Lilly Co Eli | Prodrugs of excitatory amino acids |
| US7038077B2 (en) * | 2001-01-11 | 2006-05-02 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| WO2002068380A1 (fr) * | 2001-02-22 | 2002-09-06 | Eli Lilly And Company | Acides amines excitateurs synthetiques |
| KR20090031962A (ko) * | 2001-12-27 | 2009-03-30 | 다이쇼 세이야꾸 가부시끼가이샤 | 6-플루오로비시클로[3.1.0]헥산 유도체 |
| US20040116489A1 (en) * | 2002-02-12 | 2004-06-17 | Massey Steven Marc | Synthetic excitatory amino acids |
| US20050192273A1 (en) * | 2002-04-03 | 2005-09-01 | Johnson Bryan G. | Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist |
| DE60325968D1 (de) * | 2002-06-11 | 2009-03-12 | Lilly Co Eli | Prodrugs von exzitatorischen aminosäuren |
| ES2355144T3 (es) | 2003-06-26 | 2011-03-23 | Taisho Pharmaceutical Co., Ltd. | Derivado de éster 2-aminobiciclo 3.1.0 hexano-2,6-dicarboxílico. |
| US7960579B2 (en) | 2003-06-26 | 2011-06-14 | Taisho Pharmaceutical Co., Ltd. | 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic ester derivative |
| RU2409557C2 (ru) * | 2003-06-26 | 2011-01-20 | Таишо Фармасьютикал Ко., Лтд. | Сложноэфирное производное 2-амино-бицикло[3.1.0]гексан-2,6-дикарбоновой кислоты |
| US7381746B2 (en) | 2003-06-26 | 2008-06-03 | Taisho Pharmaceutical Co., Ltd. | 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| US7786314B2 (en) * | 2003-11-07 | 2010-08-31 | Taisho Pharmaceutical Co., Ltd | Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto |
| US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
| CN101272781A (zh) | 2005-07-27 | 2008-09-24 | 多夫药品公司 | 新的1-芳基-3-氮杂二环[3.1.0]己烷:其制备方法和用于治疗神经精神障碍的用途 |
| EP2258357A3 (fr) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenèse avec inhibiteur de l'acetylcholinestérase |
| AU2006282896A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| WO2007047978A2 (fr) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation de la neurogenese par inhibition de la pde |
| JP2009513672A (ja) | 2005-10-31 | 2009-04-02 | ブレインセルス,インコーポレイティド | 神経発生のgaba受容体媒介調節 |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20080045725A1 (en) * | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| EP2377531A2 (fr) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogénèse par modulation de l'angiotensine |
| US7998971B2 (en) | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20080269348A1 (en) * | 2006-11-07 | 2008-10-30 | Phil Skolnick | Novel Arylbicyclo[3.1.0]Hexylamines And Methods And Compositions For Their Preparation And Use |
| US8138377B2 (en) * | 2006-11-07 | 2012-03-20 | Dov Pharmaceutical, Inc. | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
| EP3699162B1 (fr) | 2006-11-08 | 2022-06-29 | Molecular Insight Pharmaceuticals, Inc. | Hétérodimères d'acide glutamique |
| US8586619B2 (en) * | 2007-03-12 | 2013-11-19 | Vm Therapeutics Llc | Agents of calcium ion channel modulators |
| US9133159B2 (en) | 2007-06-06 | 2015-09-15 | Neurovance, Inc. | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| WO2008153937A2 (fr) * | 2007-06-06 | 2008-12-18 | Dov Pharmaceutical, Inc. | Nouveaux 1- hétéroaryl-3-azabicyclo[3.1.0]hexanes, leurs méthodes de préparation et leur utilisation comme médicaments |
| WO2009142184A1 (fr) * | 2008-05-21 | 2009-11-26 | 大正製薬株式会社 | Procédé de production de dérivé de bicyclo[3.1.0]hexane à l’aide d’une enzyme |
| WO2010065899A2 (fr) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Complexes de technétium- et rhénium-bis (hétéroaryles) et leurs procédés d'utilisation |
| WO2010099217A1 (fr) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine |
| WO2010111080A2 (fr) | 2009-03-27 | 2010-09-30 | Eli Lilly And Company | Traitement optimisé de la schizophrénie |
| AU2010260195B2 (en) | 2009-06-15 | 2014-11-20 | Molecular Insight Pharmaceuticals, Inc. | Process for production of heterodimers of glutamic acid |
| AR079343A1 (es) | 2009-12-21 | 2012-01-18 | Lilly Co Eli | Compuesto de acido 2-amino-4-(4h-1,2,4-triazol-3-ilsulfanil)biciclo[3.1.0]hexano-2,6-dicarboxilico, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar un trastorno psiquiatrico |
| AR083845A1 (es) * | 2010-11-18 | 2013-03-27 | Lilly Co Eli | COMPUESTOS 3-FENILSULFANILMETIL-BICICLO[3.1.0]HEXANO 4-SUSTITUIDOS COMO ANTAGONISTAS DE mGluR2/3 |
| KR101554793B1 (ko) * | 2010-11-18 | 2015-09-21 | 일라이 릴리 앤드 캄파니 | mGluR 2/3 길항제로서의 4-치환된-3-벤질옥시-비시클로[3.1.0]헥산 화합물 |
| US9296710B2 (en) * | 2011-06-17 | 2016-03-29 | Eli Lilly And Company | Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist |
| US20140206740A1 (en) | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
| EP2800471A4 (fr) | 2012-01-06 | 2015-11-04 | Molecular Insight Pharm Inc | Complexe métalliques de poly (carboxyl) amine contenant des ligands ayant une affinité pour l'anhydrase carbonique ix |
| AR089718A1 (es) | 2012-02-01 | 2014-09-10 | Lilly Co Eli | AGONISTAS DE mGlu2/3 |
| ES2648096T3 (es) | 2013-01-14 | 2017-12-28 | Molecular Insight Pharmaceuticals, Inc. | Radiofármacos a base de triazina y agentes de radioformación de imágenes |
| FR3050021B1 (fr) | 2016-04-06 | 2018-10-19 | Nitrates & Innovation | Ensemble de deux reservoirs prets a etre assembles par vissage pour former une cartouche d'explosif bi-composant |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3325095A (en) * | 1994-08-12 | 1996-03-07 | Eli Lilly And Company | Composition and method for protection against drug dependency |
| PL182285B1 (pl) * | 1994-08-12 | 2001-12-31 | Lilly Co Eli | Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL |
| ES2162936T3 (es) * | 1994-08-12 | 2002-01-16 | Lilly Co Eli | Tratamiento de la ansiedad. |
| US5661184A (en) * | 1994-08-12 | 1997-08-26 | Eli Lilly And Company | Psychiatric agents |
| IL118727A (en) * | 1995-06-29 | 2003-01-12 | Lilly Co Eli | (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid |
| US5912248A (en) | 1995-11-16 | 1999-06-15 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| GB9605429D0 (en) * | 1995-11-16 | 1996-05-15 | Lilly Co Eli | Excitatory amino acid receptor antagonists |
| ZA969485B (en) | 1995-11-16 | 1998-05-12 | Lilly Co Eli | Excitatory amino acid receptor antagonists. |
| ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
-
1998
- 1998-05-08 ZA ZA9803930A patent/ZA983930B/xx unknown
- 1998-05-12 CO CO98026351A patent/CO4950558A1/es unknown
- 1998-05-13 US US09/078,337 patent/US5958960A/en not_active Expired - Lifetime
- 1998-05-13 DE DE69800430T patent/DE69800430T2/de not_active Expired - Lifetime
- 1998-05-13 AT AT98303730T patent/ATE198190T1/de not_active IP Right Cessation
- 1998-05-13 ES ES98303730T patent/ES2152738T3/es not_active Expired - Lifetime
- 1998-05-13 SI SI9830021T patent/SI0878463T1/xx unknown
- 1998-05-13 DK DK98303730T patent/DK0878463T3/da active
- 1998-05-13 PT PT98303730T patent/PT878463E/pt unknown
- 1998-05-13 AR ARP980102224A patent/AR015664A1/es active IP Right Grant
- 1998-05-13 EP EP98303730A patent/EP0878463B1/fr not_active Expired - Lifetime
- 1998-05-14 EA EA199901029A patent/EA199901029A1/ru unknown
- 1998-05-14 SV SV1998000056A patent/SV1998000056A/es unknown
- 1998-05-14 ID IDW991344A patent/ID23183A/id unknown
- 1998-05-14 KR KR1019997010444A patent/KR20010012489A/ko not_active Withdrawn
- 1998-05-14 CA CA002289472A patent/CA2289472C/fr not_active Expired - Fee Related
- 1998-05-14 WO PCT/US1998/009862 patent/WO1998051655A1/fr not_active Ceased
- 1998-05-14 AU AU73869/98A patent/AU729632B2/en not_active Ceased
- 1998-05-14 TR TR1999/02777T patent/TR199902777T2/xx unknown
- 1998-05-14 PL PL98336793A patent/PL336793A1/xx unknown
- 1998-05-14 NZ NZ500954A patent/NZ500954A/en unknown
- 1998-05-14 PE PE1998000370A patent/PE73599A1/es not_active Application Discontinuation
- 1998-05-14 CN CN98804992A patent/CN1125807C/zh not_active Expired - Fee Related
- 1998-05-14 HU HU0001404A patent/HUP0001404A3/hu unknown
- 1998-05-14 TW TW087107483A patent/TW505623B/zh active
- 1998-05-14 IL IL13289498A patent/IL132894A0/xx unknown
- 1998-05-14 BR BR9808787-8A patent/BR9808787A/pt active Search and Examination
- 1998-05-14 JP JP54954398A patent/JP4191263B2/ja not_active Expired - Fee Related
-
1999
- 1999-05-28 US US09/322,651 patent/US6160009A/en not_active Expired - Lifetime
- 1999-11-09 NO NO995480A patent/NO995480D0/no not_active Application Discontinuation
-
2000
- 2000-08-11 US US09/637,143 patent/US6268507B1/en not_active Expired - Lifetime
- 2000-12-27 GR GR20000402844T patent/GR3035156T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0878463T3 (da) | Excitatoriske aminosyrereceptormodulatorer | |
| DE69908535D1 (de) | Modulatoren von exzitatorischen Aminosäure Rezeptoren | |
| AU5073600A (en) | Excitatory amino acid receptor modulators | |
| FI933810A7 (fi) | Virittyvien aminohappojen reseptoriantagonisteja | |
| FI945704A7 (fi) | Eksitatorisen aminohapporeseptorin antagonisteja | |
| BR9611509A (pt) | Antagonistas de receptores de aminoácidos excitativos | |
| NO993901D0 (no) | Bisykliske aminosyrer | |
| DE69604999D1 (de) | Brückenverbinder | |
| ATE319685T1 (de) | Exzitatorisch wirkende aminosäurederivate | |
| NO995299L (no) | Kalsitonin reseptorbindende peptider | |
| BR9609671A (pt) | Amino uracilas substituídas | |
| DE69705017D1 (de) | Medikamente bindendes Protein | |
| DE69513832D1 (de) | Exzitatorische aminosäure-rezeptor-antagonisten | |
| BR9611521A (pt) | Antagonistas de receptor de aminoácido excitador | |
| DE69837870D1 (de) | Lichtmodulatoren | |
| AU6455501A (en) | Excitatory amino acid receptor modulators | |
| AU2001264554A1 (en) | Excitatory amino acid receptor modulators | |
| FI973602A0 (fi) | Modulaer omformare | |
| DK1017798T3 (da) | Lunasinpeptider | |
| NO20000976D0 (no) | Peptider | |
| SE9704481D0 (sv) | System Architecture | |
| AU2001264555A1 (en) | Excitatory amino acid receptor modulators | |
| DK0937139T3 (da) | Amidase | |
| NO974296D0 (no) | Aminosyreforbindelse | |
| NL1005484A1 (nl) | Tuibrug. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |